文献速递淋巴瘤

疾病部位作为结外受累的系统性间变性淋巴瘤激酶阳性间变性大细胞淋巴瘤患者生存结局的决定因素:基于美国国家癌症数据库1306例的分析

Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database.
PubMed 文献 · Br J Haematol · 2018-03-30

基于美国国家癌症数据库2004至2014年诊断的1306例伴结外受累的ALK阳性间变性大细胞淋巴瘤患者,分析不同原发结外部位对生存的影响。经混杂变量校正后,中枢神经系统和胸/腹/盆腔受累者总生存短于头颈、骨和皮肤/皮下组织受累者。作者推荐对这类患者 upfront 采用更激进的治疗。

要点

  • 伴结外受累的ALK阳性ALCL中,胸/腹/盆腔387例、骨103例、中枢神经系统62例、头颈134例、皮肤/软组织620例。
  • 较年轻、较低Charlson-Deyo评分、较低临床分期、接受化疗和接受放疗是总生存较长的预测因素。
  • 校正混杂变量后,中枢神经系统和胸/腹/盆腔受累者总生存短于头颈、骨和皮肤/皮下组织受累者。

核心结论

  • 校正混杂变量后,中枢神经系统和胸/腹/盆腔结外受累的ALK阳性ALCL患者总生存短于头颈、骨和皮肤/皮下组织受累者。
  • 作者推荐对这类患者 upfront 采用更激进的治疗。

研究设计与样本

  • 基于美国国家癌症数据库的回顾性分析,纳入2004年至2014年诊断的1306例伴结外受累的ALK阳性间变性大细胞淋巴瘤患者。

主要发现

  • 1306例中,原发结外部位为胸/腹/盆腔387例、骨103例、中枢神经系统62例、头颈134例、皮肤/软组织620例。
  • 较年轻、较低Charlson-Deyo评分、较低临床分期、接受化疗和接受放疗是总生存较长的预测因素。
  • 校正混杂变量后,中枢神经系统和胸/腹/盆腔受累者总生存短于头颈、骨和皮肤/皮下组织受累者。

临床怎么用

  • 作者推荐对中枢神经系统和胸/腹/盆腔结外受累的ALK阳性ALCL患者 upfront 采用更激进的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic anaplastic lymphoma kinase positive (ALK+) anaplastic large cell lymphoma with extranodal involvement (ALCL-E) is a rare form of non-Hodgkin lymphoma. No large study in the literature has compared the survival outcomes among different primary extranodal sites of involvement in ALK+ ALCL-E. We identified 1306 patients with ALK+ ALCL-E diagnosed between 2004 and 2014 in the US National Cancer Database, among whom 387 had primary extranodal site in the chest/abdomen/pelvis, 103 in the bone, 62 in the central nervous system, 134 in the head and neck and 620 in the cutaneous/soft tissue. Younger age, lower Charlson-Deyo score, lower clinical stage, receipt of chemotherapy and receipt of radiotherapy were predictors of longer overall survival. Patients with extranodal involvement of central nervous system and chest/abdomen/pelvis had shorter overall survival than those with involvement of head and neck, bone, and cutaneous/subcutaneous tissue after adjusting for confounding variables. We recommend treating these patients upfront with more aggressive therapy.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Nguyen KA, Su C, Bai HX, et al. Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database. Br J Haematol. 2018. PMID: 29602182. doi:10.1111/bjh.15145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。